Back to Trades
BOBULSKY SUSAN
Chief Commercial OfficerMRDCIK 0001820885
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 8
- Buy transactions
- 0
- Sell transactions
- 8
- Companies
- 1
- Active
- 2026
BOBULSKY SUSAN, Chief Commercial Officer, MRD, has filed 8 SEC reports (2026), all concentrated in Adaptive Biotechnologies Corp (ADPT), totaling $1.2M in disclosed volume. Weighing $0 bought versus $1.2M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
8 loaded
| Aug 12 | ADPT Adaptive Biotechnologies Corp | BOBULSKY SUSAN | Chief Commercial Officer, MRD | Sell | $75.0K |
| Aug 3 | ADPT Adaptive Biotechnologies Corp | BOBULSKY SUSAN | Chief Commercial Officer, MRD | Sell | $31.2K |
| Jul 20 | ADPT Adaptive Biotechnologies Corp | BOBULSKY SUSAN | Chief Commercial Officer, MRD | Sell | $115.0K |
| Jul 6 | ADPT Adaptive Biotechnologies Corp | BOBULSKY SUSAN | Chief Commercial Officer, MRD | Sell | $10.7K |
| Jun 29 | ADPT Adaptive Biotechnologies Corp | BOBULSKY SUSAN | Chief Commercial Officer, MRD | Sell | $102.5K |
| Jun 15 | ADPT Adaptive Biotechnologies Corp | BOBULSKY SUSAN | Chief Commercial Officer, MRD | Sell | $95.0K |
| Jun 8 | ADPT Adaptive Biotechnologies Corp | BOBULSKY SUSAN | Chief Commercial Officer, MRD | Sell | $198.0K |
| Mar 13 | ADPT Adaptive Biotechnologies Corp | BOBULSKY SUSAN | Chief Commercial Officer, MRD | Sell | $544.4K |
8 filings